Long-term risk of ischemic heart disease following Hodgkin lymphoma treatment

被引：0
|
作者：
Van Nimwegen, F. A. [1 ]
Schaapveld, M. [1 ]
Krol, A. D. G. [2 ]
Janus, C. M. P. [3 ]
Cutter, D. [4 ]
Darby, S. [5 ]
Aleman, B. M. P. [1 ]
Van Leeuwen, F. E. [1 ]
机构：
[1] Netherlands Canc Inst, Amsterdam, Netherlands
[2] Leiden Univ, Med Ctr, Leiden, Netherlands
[3] Erasmus MC Daniel den Hoed Canc Ctr, Rotterdam, Netherlands
[4] Oxford Univ Hosp NHS Trust, Oxford Canc Ctr, Oxford, England
[5] Univ Oxford, Clin Trial Serv Unit, Oxford, England
来源：
EUROPEAN JOURNAL OF CANCER | 2013年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1081
引用
收藏
页码：S227 / S227
页数：1
相关论文
共 50 条
  • [31] Long-Term Clinical Outcomes Following Revascularization in High-Risk Coronary Anatomy Patients With Stable Ischemic Heart Disease
    Bainey, Kevin R.
    Alemayehu, Wendimagegn
    Welsh, Robert C.
    Kumar, Arnav
    King, Spencer B., III
    Kirtane, Ajay J.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2021, 10 (01): : 1 - 12
  • [32] Incidence of cardiovascular disease in long-term survivors of Hodgkin's lymphoma (HL)
    Aleman, B
    Klokman, W
    Mulder, I
    Bartelink, H
    van Leeuwen, F
    ANNALS OF ONCOLOGY, 2005, 16 : 117 - 118
  • [33] Association of ischemic heart disease with long-term risk of cognitive decline and dementia: A cohort study
    Imahori, Yume
    Vetrano, Davide L.
    Ljungman, Petter
    Laukka, Erika J.
    Wu, Jing
    Grande, Giulia
    Rizzuto, Debora
    Fratiglioni, Laura
    Qiu, Chengxuan
    ALZHEIMERS & DEMENTIA, 2023, 19 (12) : 5541 - 5549
  • [34] Risk factors for mortality and ischemic heart disease in patients with long-term type 1 diabetes
    Grauslund, Jakob
    Jorgensen, Trine M. M.
    Nybo, Mads
    Green, Anders
    Rasmussen, Lars M.
    Sjolie, Anne Katrin
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2010, 24 (04) : 223 - 228
  • [35] Long-Term Efficacy of Treatment in Elderly Patients With Hodgkin Lymphoma: A Retrospective Analysis
    Terzieva, Slobodanka Trpkovska
    Amzai, Gazmend
    Pavkovik, Marica
    Sotirova, Tatjana
    Stavrik, Sonja Genadieva
    Stojanoski, Zlate
    Mojsovska, Tara
    Jakimovska, Simona Stojanovska
    Jakimovski, Mario
    Karanfilski, Oliver
    Stavridis, Irina Panovska
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S446 - S446
  • [36] LONG-TERM RISK OF CARDIAC AND VALVULAR DISEASE AFTER INVOLVED NODE RADIOTHERAPY AND MANTLE FIELD FOR HODGKIN LYMPHOMA
    Maraldo, M. V.
    Brodin, N. P.
    Vogelius, I. R.
    Aznar, M.
    Afrosenschold, P. M.
    Petersen, P. M.
    Specht, L.
    ANNALS OF ONCOLOGY, 2011, 22 : 182 - 182
  • [37] Chronic fatigue in long-term survivors of Hodgkin's lymphoma after contemporary risk-adapted treatment
    Eikeland, Siri A.
    Smeland, Knut B.
    Simensen, Victoria Charlotte
    Fagerli, Unn-Merete
    Bersvendsen, Hanne S.
    Kiserud, Cecilie E.
    Fossa, Alexander
    ACTA ONCOLOGICA, 2023, 62 (01) : 80 - 88
  • [38] LONG-TERM Risk of Late Effects After Treatment for EARLY-STAGE HODGKIN'S Lymphoma (HL)
    Viviani, Simonetta
    DI Russo, Anna
    Bonfante, Valeria
    Valagussa, Pinuccia
    Bonadonna, Gianni
    Gianni, Alessandro M.
    BLOOD, 2012, 120 (21)
  • [39] Long-term risk of solid tumors in survivors of Hodgkin's disease
    Van Leeuwen, FE
    Klokman, WJ
    Hagenbeek, A
    Van 't Veer, MB
    Baars, JW
    Aleman, BMP
    Russell, NS
    Somers, R
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (01) : 271 - 271
  • [40] Long-term complications in Hodgkin's lymphoma survivors
    Kilickap, Saadettin
    Barista, Ibrahim
    Ulger, Sukran
    Celik, Ismail
    Selek, Ugur
    Gullu, Ibrahim
    Yildiz, Ferah
    Kars, Ayse
    Ozisik, Yavuz
    Tekuzman, Gulten
    TUMORI, 2012, 98 (05) : 601 - 606
12345